Physician profile
Nicholas Pappas
NPI 1912079120
$2,944.50
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,129 · 2020: $300 · 2021: $480 · 2022: $34.83.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $434.50 | 2019-2021 | |
| Pfizer INC. | $392.60 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $352.01 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $262.87 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $202.79 | 2019-2020 | |
| Amgen INC. | $202.72 | 2019-2021 | |
| Abiomed | $150.46 | 2019 | |
| Amarin Pharma, INC. | $147.68 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $125.96 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.97 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $95.62 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.41 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $74.38 | 2019-2021 | |
| Gilead Sciences, INC. | $68.17 | 2019 | |
| Esperion Therapeutics, INC. | $55.20 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $49.29 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $33.81 | 2019 | |
| Terumo Medical Corporation | $31.41 | 2019 | |
| Genzyme Corporation | $18.74 | 2022 | |
| United Therapeutics Corporation | $13.97 | 2019 | |
| Medtronic Vascular, INC. | $13.83 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Pappas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.